Monitoring Agency Report for the quarter ended March 31, 2026
UPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings has submitted the final monitoring report for UPL's ₹3,377.74 crore rights issue (completed December 2024). All proceeds have been fully utilized with zero deviation from the stated objects. ₹3,003.9 crore was used for prepayment and repayment of outstanding borrowings, ₹341.9 crore for general corporate purposes (working capital/vendor payments), and ₹23.1 crore for issue-related expenses. The only minor reallocation noted was that savings of ₹8.1 crore from lower issue expenses were diverted to general corporate purposes as permitted under the Letter of Offer. This is the final monitoring report confirming complete deployment of rights issue funds.
Neutral for shareholders. The filing confirms UPL deployed all rights issue proceeds as promised with no material deviations, indicating disciplined use of capital raised. No impact on stock expected.